The Enzen Trial: Comparison of Evar Endoprosthesis: Endurant Versus Zenith

Hospital do Servidor Publico Estadual100 enrolled

Overview

A prospective, non-randomized trial of patients submitted to EVAR for aortoiliac aneursym using Endurant II (Medtronic) or Zenith (Cook).

A prospective, non-randomized trial of patients submitted to EVAR for aortoiliac aneursym using Endurant II (Medtronic) or Zenith (Cook). The patients will be evaluated in a follow-up, regarding overall mortality rate, perioperative mortality rate and outcomes, such as Endoleaks and reinterventions.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Aortic Aneurysm Aortoiliac Atherosclerosis

Interventions

EVARDEVICE

Endovascular repair of aortoiliac aneurysm using Zenith or Endurant

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: Aortoiliac infra-renal aneurysms. \- Exclusion Criteria: Thoracoabdominal aortic aneurysms, pararenal and supra-renal aortic aneurysms * Patients not suitable for EVAR.

Locations (1)

Hospital do Servidor Público Estadual de São Paulo

São Paulo, São Paulo, Brazil

Outcomes

Primary Outcomes

Perioperative Mortality rate

Mortality rate

Time frame: 30 days

Secondary Outcomes

Reinterventions

Reinterventions during follow-up

Time frame: 2 years

Endoleaks

Endoleaks during follow-up

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.